Defender Capital’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Defender Capital’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-30,000	Closed	-$547K	–	43
2021 Q1	$547K	Hold	30,000	–	–	0.2%	26
2020 Q4	$346K	Hold	30,000	–	–	0.15%	26
2020 Q3	$229K	Hold	30,000	–	–	0.11%	26
2020 Q2	$197K	Hold	30,000	–	–	0.12%	24
2020 Q1	$153K	Buy	+30,000	New	+$182K	0.11%	18

Other funds holding CDMO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Defender Capital's CDMO Position: Q2 2021 in Review

Defender Capital sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2021, closing a stake of 30,000 shares — an estimated $547K sold.

Defender Capital first reported a position in CDMO in Q1 2020 and held it in 5 quarters. The position peaked at $547K in Q1 2021. 172 funds tracked by Wall St. Rank hold CDMO as of Q2 2021.

Defender Capital reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Defender Capital sold 30,000 Avid Bioservices, Inc. Common Stock shares in Q2 2021, an estimated $547K.
Defender Capital first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
Defender Capital's Avid Bioservices, Inc. Common Stock position peaked at $547K in Q1 2021.
172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2021.

Based on Defender Capital's 13F filing for Q2 2021, filed 29 Jul 2021.